Literature DB >> 23073045

ITP in children: pathophysiology and current treatment approaches.

John A D'Orazio1, Jessica Neely, Nina Farhoudi.   

Abstract

Primary immune thrombocytopenia (ITP) is one of the most common bleeding disorders of childhood. In most cases, it presents with sudden widespread bruising and petechiae in an otherwise well child. Thought to be mainly a disorder of antibody-mediated platelet destruction, ITP can be self-limited or develop into a chronic condition. In this review, we discuss current concepts of the pathophysiology and treatment approaches to pediatric ITP.

Entities:  

Mesh:

Year:  2013        PMID: 23073045     DOI: 10.1097/MPH.0b013e318271f457

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  9 in total

1.  Newly diagnosed immune thrombocytopenia: update on diagnosis and management.

Authors:  Deepak Bansal; Aruna Rajendran; Sunit Singhi
Journal:  Indian J Pediatr       Date:  2013-10-05       Impact factor: 1.967

2.  B-cell hyperfunction in children with immune thrombocytopenic purpura persists after splenectomy.

Authors:  Paola Giordano; Simona Cascioli; Giuseppe Lassandro; Valentina Marcellini; Fabio Cardinale; Federica Valente; Franco Locatelli; Rita Carsetti
Journal:  Pediatr Res       Date:  2015-10-22       Impact factor: 3.756

3.  Effect of short-term, high-dose methylprednisolone on oxidative stress in children with acute immune thrombocytopenia.

Authors:  Musa Cura; Ahmet Koç; Nurten Aksoy; Zeynep Canan Özdemir
Journal:  Blood Res       Date:  2016-12-23

4.  The study of transcriptome sequencing in childhood immune thrombocytopenia.

Authors:  Congcong Sun; Lixian Chang; Yanling Lv; Jinxia Guan; Xiaofan Zhu
Journal:  Blood Coagul Fibrinolysis       Date:  2019-12       Impact factor: 1.276

5.  Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management.

Authors:  Adam Cuker; Ann D Bass; Congor Nadj; Mark A Agius; Brian Steingo; Krzysztof W Selmaj; Timothy Thoits; Alexandre Guerreiro; Bart Van Wijmeersch; Tjalf Ziemssen; Sven G Meuth; Christopher C LaGanke; Karthinathan Thangavelu; Claudio E Rodriguez; Darren P Baker; David H Margolin; Ann Jannsens
Journal:  Mult Scler       Date:  2019-02-20       Impact factor: 6.312

6.  Use of bioinformatic analyses in identifying characteristic genes and mechanisms active in the progression of idiopathic thrombocytopenic purpura in individuals with different phenotypes.

Authors:  Mengyi Zhang; Binhan Guo
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

Review 7.  Immune Thrombocytopenic Purpura as a Hemorrhagic Versus Thrombotic Disease: An Updated Insight into Pathophysiological Mechanisms.

Authors:  Claudia Cristina Tărniceriu; Loredana Liliana Hurjui; Irina Daniela Florea; Ion Hurjui; Irina Gradinaru; Daniela Maria Tanase; Carmen Delianu; Anca Haisan; Ludmila Lozneanu
Journal:  Medicina (Kaunas)       Date:  2022-02-01       Impact factor: 2.430

8.  Prenatal Exposure to Air Pollution and Immune Thrombocytopenia: A Nationwide Population-Based Cohort Study.

Authors:  Hsin-Chien Yen; Chien-Heng Lin; Ming-Chih Lin; Ya-Chi Hsu; Yi-Hsuan Lin
Journal:  Front Pediatr       Date:  2022-03-18       Impact factor: 3.418

Review 9.  Use of Thrombopoietin Receptor Agonists in Childhood Immune Thrombocytopenia.

Authors:  Angelica Maria Garzon; William Beau Mitchell
Journal:  Front Pediatr       Date:  2015-08-13       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.